Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,869,549
-$7,767,764 QoQ
Shares Held
892,471
-15.8% QoQ
Ownership
0.922%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#27
of 314 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. XENE ranks #20 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
|
92,880 | $86,171,277 |
All Filings in XENE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,869,549 | 892,471 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $61,637,313 | 1,059,971 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,043,504 | 447,200 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,846,940 | 419,600 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $29,668,550 | 947,877 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $31,801,273 | 947,877 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $37,156,778 | 947,877 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $35,882,605 | 911,420 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $33,623,494 | 862,362 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $23,677,500 | 550,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $25,333,000 | 550,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $32,752,368 | 958,793 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $42,196,000 | 1,096,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $41,126,289 | 1,149,100 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $45,309,013 | 1,149,100 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $41,056,530 | 1,137,300 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $40,434,264 | 1,329,200 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $20,971,020 | 686,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $19,712,440 | 631,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,288,560 | 477,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,843,120 | 1,334,217 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $44,712,714 | 2,497,917 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $38,417,963 | 2,497,917 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $27,651,941 | 2,497,917 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $31,323,879 | 2,497,917 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $18,856,288 | 1,662,812 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||